271 related articles for article (PubMed ID: 10092796)
21. Processing of an endogenous protein can generate MHC class II-restricted T cell determinants distinct from those derived from exogenous antigen.
Moreno J; Vignali DA; Nadimi F; Fuchs S; Adorini L; Hämmerling GJ
J Immunol; 1991 Nov; 147(10):3306-13. PubMed ID: 1658143
[TBL] [Abstract][Full Text] [Related]
22. Downmodulation of antigen presentation by H2-O in B cell lines and primary B lymphocytes.
Brocke P; Armandola E; Garbi N; Hämmerling GJ
Eur J Immunol; 2003 Feb; 33(2):411-21. PubMed ID: 12645938
[TBL] [Abstract][Full Text] [Related]
23. Single amino acid mutations in the murine MHC class II A beta cytoplasmic domain abrogate antigen presentation.
Laufer TM; Smiley ST; Ranger A; Clements VK; Ostrand-Rosenberg S; Glimcher LH
J Immunol; 1997 Dec; 159(12):5914-20. PubMed ID: 9550388
[TBL] [Abstract][Full Text] [Related]
24. Antigen presentation by dendritic cells focuses T cell responses against immunodominant peptides: studies in the hen egg-white lysozyme (HEL) model.
Gapin L; Bravo de Alba Y; Casrouge A; Cabaniols JP; Kourilsky P; Kanellopoulos J
J Immunol; 1998 Feb; 160(4):1555-64. PubMed ID: 9469410
[TBL] [Abstract][Full Text] [Related]
25. Large protein fragments as substrates for endocytic antigen capture by MHC class II molecules.
Castellino F; Zappacosta F; Coligan JE; Germain RN
J Immunol; 1998 Oct; 161(8):4048-57. PubMed ID: 9780175
[TBL] [Abstract][Full Text] [Related]
26. Targeting major histocompatibility complex class II molecules to the cell surface by invariant chain allows antigen presentation upon recycling.
Nijenhuis M; Calafat J; Kuijpers KC; Janssen H; de Haas M; Nordeng TW; Bakke O; Neefjes JJ
Eur J Immunol; 1994 Apr; 24(4):873-83. PubMed ID: 8149958
[TBL] [Abstract][Full Text] [Related]
27. Distinct effects of recombinant cholera toxin B subunit and holotoxin on different stages of class II MHC antigen processing and presentation by macrophages.
Matousek MP; Nedrud JG; Harding CV
J Immunol; 1996 Jun; 156(11):4137-45. PubMed ID: 8666780
[TBL] [Abstract][Full Text] [Related]
28. Intracellular interference with antigen presentation.
Leyva-Cobian F; Unanue ER
J Immunol; 1988 Sep; 141(5):1445-50. PubMed ID: 3137257
[TBL] [Abstract][Full Text] [Related]
29. Fc epsilon receptor I on dendritic cells delivers IgE-bound multivalent antigens into a cathepsin S-dependent pathway of MHC class II presentation.
Maurer D; Fiebiger E; Reininger B; Ebner C; Petzelbauer P; Shi GP; Chapman HA; Stingl G
J Immunol; 1998 Sep; 161(6):2731-9. PubMed ID: 9743330
[TBL] [Abstract][Full Text] [Related]
30. The actin-based motor protein myosin II regulates MHC class II trafficking and BCR-driven antigen presentation.
Vascotto F; Lankar D; Faure-André G; Vargas P; Diaz J; Le Roux D; Yuseff MI; Sibarita JB; Boes M; Raposo G; Mougneau E; Glaichenhaus N; Bonnerot C; Manoury B; Lennon-Duménil AM
J Cell Biol; 2007 Mar; 176(7):1007-19. PubMed ID: 17389233
[TBL] [Abstract][Full Text] [Related]
31. Deletion of a C-terminal sequence of the class II-associated invariant chain abrogates invariant chains oligomer formation and class II antigen presentation.
Bertolino P; Staschewski M; Trescol-Biémont MC; Freisewinkel IM; Schenck K; Chrétien I; Forquet F; Gerlier D; Rabourdin-Combe C; Koch N
J Immunol; 1995 Jun; 154(11):5620-9. PubMed ID: 7751615
[TBL] [Abstract][Full Text] [Related]
32. Regulation of B cell receptor-mediated MHC class II antigen processing by FcgammaRIIB1.
Wagle NM; Faassen AE; Kim JH; Pierce SK
J Immunol; 1999 Mar; 162(5):2732-40. PubMed ID: 10072518
[TBL] [Abstract][Full Text] [Related]
33. Two processing pathways for the MHC class II-restricted presentation of exogenous influenza virus antigen.
Pinet V; Malnati MS; Long EO
J Immunol; 1994 May; 152(10):4852-60. PubMed ID: 8176208
[TBL] [Abstract][Full Text] [Related]
34. Cathepsin D, but not cathepsin B, releases T cell stimulatory fragments from lysozyme that are functional in the context of multiple murine class II MHC molecules.
van Noort JM; Jacobs MJ
Eur J Immunol; 1994 Sep; 24(9):2175-80. PubMed ID: 8088334
[TBL] [Abstract][Full Text] [Related]
35. Analysis of MHC class II presentation of particulate antigens of B lymphocytes.
Vidard L; Kovacsovics-Bankowski M; Kraeft SK; Chen LB; Benacerraf B; Rock KL
J Immunol; 1996 Apr; 156(8):2809-18. PubMed ID: 8609400
[TBL] [Abstract][Full Text] [Related]
36. CpG oligodeoxynucleotides down-regulate macrophage class II MHC antigen processing.
Chu RS; Askew D; Noss EH; Tobian A; Krieg AM; Harding CV
J Immunol; 1999 Aug; 163(3):1188-94. PubMed ID: 10415013
[TBL] [Abstract][Full Text] [Related]
37. Mutation of the invariant chain transmembrane region inhibits II degradation, prolongs association with MHC class II, and selectively disrupts antigen presentation.
Frauwirth K; Shastri N
Cell Immunol; 2001 May; 209(2):97-108. PubMed ID: 11446742
[TBL] [Abstract][Full Text] [Related]
38. Monovalent ligation of the B cell receptor induces receptor activation but fails to promote antigen presentation.
Kim YM; Pan JY; Korbel GA; Peperzak V; Boes M; Ploegh HL
Proc Natl Acad Sci U S A; 2006 Feb; 103(9):3327-32. PubMed ID: 16492756
[TBL] [Abstract][Full Text] [Related]
39. Entry of B cell antigen receptor and antigen into class II peptide-loading compartment is independent of receptor cross-linking.
Song W; Cho H; Cheng P; Pierce SK
J Immunol; 1995 Nov; 155(9):4255-63. PubMed ID: 7594583
[TBL] [Abstract][Full Text] [Related]
40. MHC class II transport from lysosomal compartments to the cell surface is determined by stable peptide binding, but not by the cytosolic domains of the alpha- and beta-chains.
Théry C; Brachet V; Regnault A; Rescigno M; Ricciardi-Castagnoli P; Bonnerot C; Amigorena S
J Immunol; 1998 Sep; 161(5):2106-13. PubMed ID: 9725201
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
